Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
NGM Biopharmaceuticals, Inc. Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 7,521,394 shares of common stock of NGM…
TransMedics Group, Inc. Initial Public Offering
Davis Polk advised the representatives of the underwriters in connection with the $104.7 million initial public offering of…
Turning Point Therapeutics, Inc. Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with a $191.5 million initial public…
Davis Polk Advises Ultra Clean on Its Acquisition of Dynamic Manufacturing Solutions
Davis Polk advised Ultra Clean Holdings, Inc. on its acquisition of substantially all of the assets of Dynamic Manufacturing…
Davis Polk Advises Williams on Its Sale of Its 50% Interest in Jackalope Gas Gathering Services to an Affiliate of Crestwood Equity Partners
Davis Polk advised The Williams Companies, Inc. on its $484.6 million sale of a 50% interest in Jackalope Gas Gathering…
Williams sale of its 50% interest in Jackalope Gas Gathering Services
We advised Williams on the sale to an affiliate of Crestwood Equity Partners
Davis Polk Advises Ferrero on Its Acquisition of Kellogg’s Cookie, Fruit Snack, Ice Cream Cone and Pie Crust Businesses
Davis Polk is advising The Ferrero Group on its $1.3 billion acquisition of Kellogg Company’s cookie, fruit and fruit…
Davis Polk Advises S&P Global on Its Sale of SPIAS
Davis Polk is advising S&P Global Inc. on the sale of its subsidiary, Standard & Poor’s Investment Advisory Services…
Davis Polk Advises ShockWave Medical, Inc. on Its $111.4 Million Initial Public Offering
Davis Polk advised ShockWave Medical, Inc. on its SEC-registered initial public offering of 6,555,000 shares of common stock…
Horizon Pharma Follow-On Offering
Davis Polk advised the underwriters in connection with the $345 million public offering of ordinary shares of Horizon Pharma…